## Background: Prostate carcinoma incidence has been declining since 1992 after a period of marked increase. recent data from the national cancer data base (ncdb) were examined to assess changes in prostate carcinoma patient characteristics and disease and treatment patterns coincidental to this de
The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.
β Scribed by Curtis J. Mettlin; Gerald P. Murphy; Charles J. McDonald; Herman R. Menck
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 80 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND. An increase in the proportion of prostate carcinomas diagnosed at early, potentially curable stages has led to several changes in treatment of patients with this disease. Greater use of radical prostatectomy and external beam radiation has been documented, and recent data suggest that the use of radiation implant (brachytherapy) also has increased. Recent results from the National Cancer Data Base (NCDB) are available to explore this trend in greater detail.
METHODS.
Data provided by 1758 hospital cancer registries for 435,264 patients diagnosed between 1992 and 1996 were studied. Reported use of brachytherapy was analyzed by year of diagnosis, region, patient age at diagnosis, and tumor grade.
π SIMILAR VOLUMES
## BACKGROUND. Previous Commission on Cancer data from the National Cancer Data Base (NCDB) have examined time trends in stage of disease, treatment patterns, and survival for selected cancers. In the current study data relating to
The Commission on Cancer data from the National Cancer Data Base (NCDB) has previously reported data evaluating time trends in various cancers, including such elements as stage of disease at diagnosis, treatment, and survival for multiple tumor sites. In this report, data collected from 1985, 1986,
The National Cancer Data Base (NCDB) represents a national electronic registry system now capturing nearly 60% of incident cancers in the U. S. In combination with other Commission on Cancer programs, the NCDB offers a working example of voluntary, accurate, cost-effective "outcomes management" on a
The natural history of chronic lymphocytic leukemia (CLL) is changing, although the reasons (potential changes in the disease's biology or in patterns in patient characteristics, treatment, or referral) are unclear. ## METHODS. This report uses National Cancer Data Base (NCDB) data, which reflect
## BACKGROUND. In combination with other Commission on Cancer programs, the National Cancer Data Base (NCDB), a national electronic registry system currently capturing ΟΎ 60% of incident cancers in the U. S., offers a working example of voluntary, accurate, cost-effective "outcomes management" on a